Sphingolipids

Kidney International

Volumn 58, Issue 1, 2000, Pages 11-26

  Shayman, James A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Cell signaling; Epilhelia; Lipids; Oncogenesis; Renal physiology

Indexed keywords

CERAMIDE; SPHINGOLIPID; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE;

APOPTOSIS; CELL DIFFERENTIATION; CELL GROWTH; KIDNEY EPITHELIUM; LIPID ANALYSIS; LYSOSOME STORAGE DISEASE; PRIORITY JOURNAL; REVIEW; STRESS;

EID: 0033947176     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00136.x     Document Type: Article

References (173)

1. 1. HOKIN LE, HOKIN MR: Evidence for phosphatidic acid as the sodium carrier. Nature 184:1068-1069, 1959
2. 2. SHAYMAN JA, RADIN NS: The structure and function of renal glycosphingolipids. Am J Physiol 260:F291-F302, 1991
3. 3. SHAYMAN JA: Sphingolipids: Their role in intracellular signaling and renal growth. J Am Soc Nephrol 7:171-182, 1996
4. 4. KARLSSON KA: On the chemistry and occurrence of sphingolipid long-chain bases. Chem Phys Lipids 5:6-43, 1970
5. 5. RADIN NS, MARTIN FB, BROWN JR: Galactolipide metabolism. J Biol Chem 224:499-507, 1957
6. 6. BAJJALIEH SM, MARTIN TFJ, FLOOR E: Synaptic vesicle ceramide kinase: A calcium-stimulated lipid kinase that co-purifies with brain synaptic vesicles. J Biol Chem 264:14917-14921, 1990
7. 7. ABE A, SHAYMAN JA, RADIN NS: A novel enzyme that catalyzes the esterification of N-acetylsphingosine. J Biol Chem 271:14383-14389, 1996
8. 8. BAR LK, BARENHOLZ Y, THOMPSON TE: Effect of sphingomyelin composition on the phase structure of phosphatidylcholine-sphingomyelin bilayers. Biochemistry 36:2507-2516, 1997
9. 9. WHITE D: Form and Function of Phospholipids. Amsterdam, Elsevier Publications, 1973, pp 441-481
10. 10. BARENHOLZ Y: Physiology of Membrane Fluidity, edited by SHINITZKY M, Sphingomyelin-lecithin balance in membranes: Composition, structure, and junction relationships, Boca Raton, CRC Press, 1984, pp 131-173
11. 11. MYERS M, WORTMAN C, FREIRE E: Modulation of neuraminidase activity by the physical state of phospholipid bilayers containing gangliosides Gd1a and Gt1b. Biochemistry 23:1442-1448, 1984
12. 12. MASSERINI M, FREIRE E: Thermotropic characterization of phosphatidylcholine vesicles containing ganglioside GM1 with homogeneous ceramide chain length. Biochemistry 25:1043-1049, 1986
13. 13. MASSERINI M, PALESTINI P, FREIRE E: Influence of glycolipid oligosaccharide and long-chain base composition on the thermotropic properties of dipalmitoylphosphatidylcholine large unilamellar vesicles containing gangliosides. Biochemistry 28:5029-5032, 1989
14. 14. FRA A, MASSERINI M, PALESTINI P, SONNINO S, SIMONS K: A photo-reactive derivative of ganglioside GM1 specifically cross-links VIP21-caveolin on the cell surface. FEBS Lett 375:11-14, 1995
15. 15. OKAMOTO T, SCHLEGEL AM, SCHERER PE, LISANTI MP: Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273:5419-5422, 1998
16. 16. BROWN DA, LONDON E: Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14:111-136, 1998
17. 17. SMART EJ, YING YS, MINEO C, ANDERSON RG: A detergent-free method for purifying caveolae membrane from tissue culture cells. Proc Natl Acad Sci USA 92:10104-10108, 1995
18. 18. IWABUCHI K, HANDA K, HAKOMORI S: Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling. J Biol Chem 273:33766-33773, 1998
19. 19. EDIDIN M: Lipid microdomains in cell surface membranes. Curr Opin Struct Biol 7:528-532, 1997
20. 20. JACOBSON K, DIETRICH C: Looking at lipid rafts? Trends Cell Biol 9:87-91, 1999
21. 21. BRADY RO, KOVAL GJ: The enzyme synthesis of sphingosine. J Biol Chem 233:26-31, 1958
22. 22. WILLIAMS RD, WANG E, MERRILL AHJ: Enzymology of long-chain base synthesis by liver: Characterization of serine palmitoyltransferase in rat liver microsomes. Arch Biochem Biophys 228:282-291, 1984
23. 23. STOFFEL W, LE KIM D, STICHT G: Synthesis and degradation of spingosine bases in Ansenula ciferrii. Hoppe Seyler's Z Physiol Chem 349:1637-1644, 1968
24. 24. SRIBNEY M: Enzymatic synthesis of ceramide. Biochim Biophys Acta 125:242-247, 1966
25. 25. ROTHER J, VAN ECHTEN G, SCHWARZMANN G, SANDHOFF K: Biosynthesis of sphingolipids: Dihydroceramide and not sphinganine is desaturated by cultured cells. Biochem Biophys Res Commun 89:14-20, 1992
26. 26. GATT S: Enzymatic hydrolysis of sphingolipids. I. Hydrolysis and synthesis of ceramides by an enzyme from rat brain. J Biol Chem 241:3724-3730, 1966
27. 27. LEE T, OU M, SHINOZAKI K, MALONE B, SNYDER F: Biosynthesis of N-acetylsphingosine by platelet-activating factor: Sphingosine CoA-independent transacetylase in HL-60 cells. J Biol Chem 271:209-217, 1996
28. 28. SRIBNEY M, KENNEDY EP: The enzymatic synthesis of sphingomyelin. J Biol Chem 233:1315-1322, 1958
29. 29. ULLMAN MD, RADIN NS: The enzymatic formation of sphingomyelin from ceramide and lecithin in mouse liver. J Biol Chem 249:1506-1513, 1974
30. 30. LIPSKY N, PAGANO RE: Sphingolipid metabolism in cultured fibroblasts: Microscopic and biochemical studies employing a fluorescent ceramide analogue. Proc Natl Acad Sci USA 80:2608-2612, 1983
31. 31. VAN DEN HILL A, VAN HEUSDEN GP, WIRTZ KWA: The synthesis of sphingomyelin in the Morris hepatomas 7777 and 5123D is restricted to the plasma membrane. Biochim Biophys Acta 833: 354-357, 1985
32. 32. Vos JP, DEHAAS CGM, CAN GOLDE LM, LOPES-GARDOZO MJ: Relationships between phosphatidylcholine, phosphatidylethanolamine, and sphingomyelin metabolism in cultured oligodendrocytes. J Neurochem 68:1252-1260, 1997
33. 33. BRADY RO, BRADLEY RM, YOUNG OM, KALLER HJ: An alternative pathway for the enzymatic synthesis of sphingomyelin. J Biol Chem 240:3693-3694, 1965
34. 34. GHOSH TK, BIAN J, GILL DL: Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science 248:1653-1656, 1990
35. 35. ITO M, KURITA T, KITA K: A novel enzyme that cleaves the N-acyl linkage of ceramides in various glycosphingolipids as well as sphingomyelin to produce their lyso forms. J Biol Chem 270: 24370-24374, 1995
36. 36. SHAYMAN JA, ABE A: Glucosylceramide synthase: Assay and properties. Methods Enzymol 311:42-49, 1999
37. 37. COSTE H, MARTEL MB, GOT R: Topology of glucosylceramide synthesis in Golgi membranes from porcine submaxillary glands. Biochim Biophys Acta 858:6-12, 1986
38. 38. DRESSLER KA, KOLESNICK RN: Ceramide 1-phosphate, a novel phospholipid in human leukemia (HL-60) cells: Synthesis via ceramide from sphingomyelin. J Biol Chem 265:14917-14921, 1990
39. 39. BOHNENBERGER E, SANDERMANN H JR: Diglyceride kinase from Escherichia coli: Purification in organic solvent and some properties of the enzyme. Eur J Biochem 94:401-407, 1979
40. 40. HINKOVSKA-GALCHEVA VT, BOXER LA, MANSFIELD PJ, HARSH D: The formation of ceramide-1-phosphate during neutrophil phagocytosis and its role in liposome fusion. J Biol Chem 273:33203-33209, 1998
41. 41. ABE A, SHAYMAN JA: Purification and characterization of 1-O-acylceramide synthase, a novel phospholipase A2. J Biol Chem 11:8467-8474, 1998
42. 42. STOFFEL W, HEIMANN G, HELLENBROICH B: Sphingosine kinase in blood platelets. Hoppe Seylers Z Physiol Chem 354:562-565, 1973
43. 43. STOFFEL W: Studies on the biosynthesis and degradation of sphingosine bases. Chem Phys Lipids 5:139-158, 1970
44. 44. WAGGONER DW, GOMEZ-MUNOZ A, DEWALD J, BRINDLEY DN: Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate. J Biol Chem 271:16506-16509, 1997
45. 45. IGARASHI Y, HAKOMORI S: Enzymatic synthesis of N,N-dimethylsphingosine: Demonstration of the sphingosine: N-methyltransferase in mouse brain. Biochem Biophys Res Commun 164:1411-1416, 1989
46. 46. MANDON EC, EHSES I, ROTHER J, VAN ECHTEN G, SANDHOFF K: Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase and sphinganine N-acyltransferase in mouse liver. J Biol Chem 267:11144-11148, 1992
47. 47. MORELL P, RADIN NS: Specificity in ceramide biosynthesis from long chain bases and various fatty acyl coenzyme As by brain microsomes. J Biol Chem 245:342-350, 1970
48. 48. VAN HELVOORT A, VAN'T HOF W, RITSEMA T, SANDRA A, VAN MEER G: Conversion of diacylglycerol to phosphatidylcholine on the basolateral surface of epithelial (Madin-Darby canine kidney) cells: Evidence for the reverse action of a sphingomyelin synthase. J Biol Chem 269:1763-1769, 1994
49. 49. BARNHOLZ Y, ROITMAN A, GATT S: Enzymatic hydrolysis of sphingolipids. II. Hydrolysis of sphingomyelin by an enzyme from rat brain. J Biol Chem 241:3731-3737, 1966
50. 2+-stimulated sphingomyelinase in fetal bovine serum. J Biol Chem 264:5358-5363, 1989
51. 51. RAO BG, SPENCE MW: Sphingomyelinase activity at pH 7.4 in human brain and a comparison to activity at pH 5.0. J Lipid Res 17:506-515, 1976
52. 52. CHAKRABORTY G, ZIEMBA S, DRIVAS A, LEDEEN RW: Myelin contains neutral sphingomyelinase activity that is stimulated by tumor necrosis factor-alpha. J Neurosci Res 50:466-476, 1997
53. 53. LEVADE T, VIDAL F, VESMEERSCH S, ANDRIEU N, GATT S, SALVAYRE R: Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway. Biochim Biophys Acta 12358:277-287, 1995
54. 54. NILSSON A: The presence of spingomyelin and ceramide-cleaving enzymes in the small intestinal tract. Biochim Biophys Acta 176:339-347, 1969
55. 55. DUAN RD, NILSSON A: Purification of a newly identified alkaline sphingomyelinase in human bile and effects of bile salts and phosphatidylcholine on enzyme activity. Hepatology 26:823-830, 1997
56. 56. SCHUCHMAN EH, SUCHI M, TAKAHASHI T, SANDHOFF K, DESNICK RJ: Human acid sphingomyelinase: Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs. J Biol Chem 266:8531-8539, 1991
57. 57. SCHISSEL SL, KEESLER GA, SCHUCHMAN EH, WILLIAMS KJ, TABAS I: The cellular trafficking and zinc dependence of secretory and lysosomal sphingomyelinase, two products of the acid sphingomyelinase gene. J Biol Chem 273:18240-18259, 1998
58. 58. TOMIUK S, HOFMANN K, NIX M, ZUMBANSEN M, STOFFEL W: Cloned mammalian neutral sphingomyelinase: Functions in sphingolipid signaling? Proc Natl Acad Sci USA 95:3638-3643, 1998
59. 59. VAN HELVOORT A, SMITH AJ, SPRONG H, FRITZSCHE I, SCHINKEL AH, BORST P, VAN MEER G: MDR1 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87:507-517, 1996
60. 60. LAVIE Y, CAO HT, BURSTEN SL, GIULIANO AE, CABOT MC: Accumulation of glucosylceramides in multidrug-resistant cancer cells. J Biol Chem 271:19530-19536, 1996
61. 61. HANNUN YA, LOOMIS CR, MERRILL AH, BELL RM: Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem 261:12604-12609, 1986
62. 62. OKAZAKI T, BELL RM, HANNUN YA: Sphingomyelin turnover induced by vitamin D3 in HL-60 cells: Role in cell differentiation. J Biol Chem 264:19076-19080, 1989
63. 63. HANNUN YA: The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269:3125-3128, 1994
64. 64. HANNUN YA, BELL RM: Lysosphingolipids inhibit protein kinase C: Implications for the sphingolipidoses. Science 235:670-674, 1987
65. 65. SPIEGEL S, CUVILLIER O, EDSALL LC, KOHAMA T, MENZELEEV R, OLAH Z, OLIVERA A, PIRIANOV G, THOMAS DM, TU Z, VAN BROOKLYN JR, WANG F: Sphingosine-1-phosphate in cell growth and cell death. Ann NY Acad Sci 845:11-18, 1998
66. 66. GOMEZ-MUNOZ A, DUFFY PA, MARTIN A, O'BRIEN L, BYUN HS, BITTMAN R, BRINDLEY DN: Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: Antagonism by cell-permeable ceramides. Mol Pharmacol 47:833-839, 1995
67. 67. WIEGMANN K, SCHÜTZE S, MACHLEIDT T, WITTE D, KRONKE M: Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005-1015, 1994
68. 68. BETTS JC, AGRANOFF AB, NABEL GJ, SHAYMAN JA: Dissociation of endogenous cellular ceramide from NK-kappa B activation. J Biol Chem 269:8455-8458, 1994
69. 2 production and sphingomyelin metabolism: Evidence for the regulation of cyclooxzygenase gene expression by sphingosine and ceramide. J Biol Chem 267:20044-20050, 1992
70. 70. VERHEIJ M, BOSE R, LIN XH, YAO B, JARVIS WD, GRANT S, BIRRER MJ, SZABO E, ZON LI, KYRIAKIS JM, HAIMOVITZ-FRIEDMAN A, FUKS Z, KOLESNICK RN: Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature 380:75-79, 1996
71. 71. BOSE R, VERHEIJ M, HAIMOVITZ-FRIEDMAN A, SCOTTO K, FUKS Z, KOLESNICK R: Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 82:405-414, 1995
72. 72. ANDRIEU N, SALVAYRE R, JAFFREZOU JP, LEVADE T: Low temperatures and hypertonicity do not block cytokine-induced stimulation of the sphingomyelin pathway but inhibit nuclear factor-kappa B activation. J Biol Chem 270:24518-24524, 1995
73. 73. SUBBARAMAIAH K, CHUNG WJ, DANNENBERG AJ: Ceramide regulates the transcription of cyclooxygenase-2: Evidence for involvement of extracellular signal-regulated kinase/c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. J Biol Chem 273:32943-32949, 1998
74. 74. CHANG Y, ABE A, SHAYMAN JA: Ceramide formation during heat shock: A potential mediator of alpha B-crystallin transcription. Proc Natl Acad Sci USA 92:12275-12279, 1995
75. 75. MASAMUNE A, IGARASHI Y, HAKOMORI S: Regulatory role of ceramide in interleukin (IL)-1-beta-induced E-selectin expression in human umbilical vein endothelial cells: Ceramide enhances IL-1 beta action, but is not sufficient for E-selectin expression. J Biol Chem 271:9368-9375, 1996
76. 76. MATHIAS S, YOUNES A, KAN CC, ORLOW I, JOSEPH C, KOLESNICK RN: Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science 259:519-522, 1993
77. 77. OLIVERA A, SPIEGEL S: Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365:557-560, 1993
78. 78. CUVILLIER O, PIRIANOV G, KLEUSER B, VANEK PG, COSO OA, GUTKIND S, SPIEGEL S: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381:800-803, 1996
79. 79. JAYADEV S, LINARDIC CM, HANNUN YA: Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha. J Biol Chem 269:5757-5763, 1994
80. 80. JACOBS LS, KESTER M: Sphingolipids as mediators of effects of platelet-derived growth factor in vascular smooth muscle cells. Am J Physiol 265:C740-C747, 1993
81. 81. BORCHARDT RA, LEE WT, KALEN A, BUCKLEY RH, PETERS C, SCHIFF S, BELL RM: Growth-dependent regulation of cellular ceramides in human T-cells. Biochim Biophys Acta 1212:327-336, 1994
82. 82. KIM MY, LINARDIC C, OBEID L, HANNUN Y: Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon: Specific role in cell differentiation. J Biol Chem 266:484-489, 1991
83. 83. DOBROWSKY RT, JENKINS GM, HANNUN YA: Neurotrophins induce sphingomyelin hydrolysis. Modulation by co-expression of p75NTR with Trk receptors. J Biol Chem 270:22135-22142, 1995
84. 84. QUINTANS J, KILKUS J, MCSHAN CL, GOTTSCHALK AR, DAWSON G: Ceramide mediates the apoptotic response of WEHI231 cells to anti-immunoglobulin, corticosteroids and irradiation. Biochem Biophys Res Commun 202:710-714, 1994
85. 85. STRUM JC, SWENSON KI, TURNER JE, BELL RM: Ceramide triggers meoitic cell cycle progression in Xenopus oocytes: A potential mediator of progesterone-induced maturation. J Biol Chem 270: 13541-13547, 1995
86. 86. GEILEN CC, BEKTAS M, WIEDER T, ORFANOS CE: The vitamin D3 analogue, calcipotriol, induces sphingomyelin hydrolysis in human keratinocytes. FEBS Lett 378:88-92, 1996
87. 87. MEACCI E, VASTA V, FARNARARO M, BRUNI P: Bradykinin increases ceramide and sphingosine content in human fibroblasts: Possible involvement of glycosphingolipids. Biochem Biophys Res Commun 221:1-7, 1996
88. 88. RIBONI L, PRINETTI A, BASSI R, CAMINITI A, TETTAMANTI G: A mediator role of ceramide in the regulation of neuroblastoma Neuro2a cell differentiation. J Biol Chem 270:26868-26875, 1995
89. 89. CATALAN RE, ARAGONES MD, MARTINEZ AM, FERNANDEZ I: Involvement of sphingolipids in the endothelin-1 signal transduction mechanism in rat brain. Neurosci Lett 220:121-124, 1996
90. 90. CIFONE MG, MARIA R, RONCAIOLI P, RIPPO MR, AZUMA M, LANIER LL, SANTONI A, TESTI R: Apoptotic signaling through CD95 (Fas/ Apo-1) activates an acidic sphingomyelinase. J Exp Med 180: 1547-1552, 1994
91. 91. BOUCHER LM, WIEGMANN K, FUTTERER A, PFEFFER K, MACHLEIDT T, SCHUTZE S, MAK TW, KRONKE M: CD28 signals through acidic sphingomyelinase. J Exp Med 181:2059-2068, 1995
92. 92. WRIGHT SC, ZHENG H, ZHONG J: Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24). FASEB J 10:325-332, 1996
93. 93. KUBOTA M, KITAHARA S, SHIMASAKI H, UETA N: Accumulation of ceramide in ischemic human brain of an acute case of cerebral occlusion. Jpn J Exp Med 59:59-64, 1989
94. 94. TURINSKY J, BAYLY BP, O'SULLIVAN DM: 1,2-Diacylglyerol and ceramide levels in rat liver and skeletal muscle in vivo. Am J Physiol 261:E620-E627, 1991
95. 95. JAFFREZOU JP, LEVADE T, BETTAIEB A, ANDRIEU N, BEZOMBES C, MAESTRE N, VERMEERSCH S, ROUSSE A, LAURENT G: Daunorubicin-induced apoptosis: Triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J 15:2416-2427, 1996
96. 96. ZHANG J, ALTER N, REED JC, BORNER C, OBEID LM, HANNUN YA: Bcl-2 interrupts the ceramide-mediated pathway of cell death. Proc Natl Acad Sci USA 93:5325-5328, 1996
97. 97. STRUM JC, SMALL GW, PAUIG SB, DANIEL LW: 1-beta-D-Arabino-furanosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells. J Biol Chem 269:15493-15497, 1994
98. 98. TETTAMANTI G, PRINETTI A, BASSI R, VIANI P, GIUSSANI P, RIBONI L: Sphingoid bioregulators in the differentiation of cells of neural origin. J Lipid Med Cell Signal 14:263-275, 1996
99. 99. JAFFREZOU JP, HERBERT JM, LEVADE T, GAU MN, CHATELAIN P, LARENT G: Reversal of multidrug resistance by calcium channel blocker SR33557 without photoaffinity labeling of P-glycoprotein. J Biol Chem 266:19858-19864, 1991
100. 100. CHMURA SJ, NODZENSKI E, WEICHSELBAUM RR, QUINTANS J: Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res 56:2711-2714, 1996
101. 101. VAN VELDHOVEN PP, MATTHEWS TJ, BOLOGNESI DP, BELL RM: Changes in bioactive lipids, aklylacylglycerol and ceramide, occur in HIV-infected cells. Biochem Biophys Res Commun 187:209-216, 1992
102. 102. HEDLUND M, SVENSSON M, NILSSON A, DUAN RD, SVANBORG C: Role of the ceramide-signaling pathway in cytokine responses to P-finbriated Escherichia coli. J Exp Med 183:1037-1044, 1996
103. 103. TAGA S, CARLIER K, MISHAL Z, CAPOULADE C, MANGENEY M, LECLUSE Y, COULAUD D, TETAUD C, PRITCHARD LL, TURSZ T, WIELS J: Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells. Blood 90:2757-2767, 1997
104. 104. WELSH N: Interleukin-1 beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J Biol Chem 271:8307-8312, 1996
105. 105. CHEN J, NIKOLOVA-KARAKASHIAN M, MERRILL AH, MORGAN ET: Regulation of cytochrome P4502C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes. J Biol Chem 270:25233-25238, 1995
106. 106. SANTANA P, LLANES L, HERNANDEZ I, GALLARDO G, QUINTANA J, GONZALEZ J: Ceramide mediates tumor necrosis factor effects on P450-aromatase activity in cultured granulosa cells. Endocrinology 136:2345-2348, 1995
107. 107. BALLOU LR, CHAO CP, HOLNESS MA, BARKER SC, RAHOW R: Interleukin-1-mediated PGE2 production and sphingomyelin metabolism: Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem 267:20044-20050, 1992
108. 108. GOLDKORN T, DRESSLER KA, MUINDI J, RADIN NS, MENDELSOHN J, MENALDINO D, LIOTTA D, KOLESNICK RN: Ceramide stimulates epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells: Evidence that ceramide may mediate sphingosine action. J Biol Chem 266:16092-16097, 1991
109. 109. RICHARD A, BOURGOIN S, NACCACHE PH, L'HEUREUX GP, KRUM E, MCCOLL SR, PELLETIER G: C2-ceramide primes specifically for the Superoxide anion production induced by N-formylmethionylleucyl phenylalanine (fMLP) in human neutrophils. Biochim Biophys Acta 1299:259-266, 1996
110. 110. Xu J, YEH CH, CHEN S, HE L, SENSI SL, CANZONIERO LM, CHOI DW, HSU CY: Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death. J Biol Chem 273:16521-16526, 1998
111. 111. NICHOLSON KM, QUINN DM, KELLETT GL, WARR JR: Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase. Br J Cancer 81:423-430, 1999
112. 112. MERONI SB, CANEPA DF, PELLIZZARI EH, SCHTEINGART HF, CIGORRAGA SB: Effect of N-acetylsphingosine (C2) and the ceramidase inhibitor (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol on the regulation of Sertoli cell function. J Androl 20:619-625, 1999
113. 113. JI L, ZHANG G, UEMATSU S, AKAHORI Y, HIRABAYASHI Y: Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett 358:211-214, 1995
114. 114. ABE A, WU D, SHAYMAN JA, RADIN NS: Metabolic effects of short-chain ceramide and glucosolyceramide on sphingolipids and protein kinase C. Eur J Biochem 210:765-773, 1992
115. 115. SIMON CG JR, GEAR AR: Membrane-destabilizing properties of C2-ceramide may be responsible for its ability to inhibit platelet aggregation. Biochem 37:2059-2069, 1998
116. 116. ZHANG P, LIU B, JENKINS GM, HANNUN YA, OBEID LM: Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis. J Biol Chem 272:9609-9612, 1997
117. 117. ABE A, RADIN NS, SHAYMAN JA, WOTRING LL, ZIPKIN RE, SIVAKUMAR R, RUGGIERI JM, CARSON KG, GANEM B: Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth. J Lipid Res 36:611-612, 1995
118. 118. SHAYMAN JA, LEE L, ABE A, SHU L: Inhibitors of glucosylceramide synthase. Methods Enzymol 311:373-387, 1999
119. 119. MERRILL AH JR, WANG E, VALES TR, SMITH ER, SCHROEDER JJ, MENALDINO DS, ALEXANDER C, CRANE HM, XIA J, LIOTTA DC, MEREDITH FI, RILEY RT: Fumonisin toxicity and sphingolipid biosynthesis. Adv Exp Med Biol 392:297-306, 1996
120. 120. BIELAWSKA A, GREENBERG MS, PERRY D, JAYADEV S, SHAYMAN J, MCKAY C, HANNUN YA: (1S,2R)-D-erythro-2-(N-myristoylamino)-1-phenyl-1-propanol as an inhibitor of ceramidase. J Biol Chem 271:12646-12654, 1996
121. 121. DOBROWSKY RT, KAMIBAYASHI C, MUMBY MC, HANNUN YA: Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 268:15523-15530, 1993
122. 122. SKRZYPEK MS, NAGIEC MM, LESTER RL, DICKSON RC: Analysis of phosphorylate sphingolipid long-chain bases reveals potential roles in heat stress and growth control in Saccharomyces. J Bacterial 181:1134-1140, 1999
123. 123. LANTERMANN MM, SABA JD: Characterization of sphingosine kinase (SK) activity in Saccharomyces cerevisiae and isolation of SK-deficient mutants. Biochem J 332:525-531, 1998
124. 124. SABA JC, NARA F, BIELAWSKA A, GARRETT S, HANNUN YA: The BST1 gene of Saccharomyces cerevisiae is the sphingosine-1-phosphate lyase. J Biol Chem 272:26087-26090, 1997
125. 125. MAO C, SABA JD, OBEID LM: The dihydrosphingosine-1-phosphate phosphatases of Saccharomyces cerevisiae are important regulators of cell proliferation and heat stress responses. Biochem J 342:667-675, 1999
126. 126. SCHUTZ S, POTTHOFF K, MACHLEIDT T, BERKOVIC D, WIEGMANN K, KRONKE M: TNF activates NF-kappa B by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765-776, 1992
127. 127. LIU B, HANNUN YA: Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J Biol Chem 272:16281-16287, 1997
128. 128. LIU B, ANDRIEU-ABADIE N, LEVADE T, ZHANG P, OBEID LM, HANNUN YA: Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem 273:11313-11320, 1998
129. 129. ADAM-KLAGES S, ADAM D, WIEGMANN K, STRUVE S, KOLANUS W, SCHNEIDER-MERGENER J, KRONKE M: FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase. Cell 86:937-947, 1996
130. 130. WINDH RT, LEE MJ, HLA T, AN S, BARR AJ, MANNING DR: Differential coupling of the sphingosine 1-phosphate receptors edg-1, edg-3, and H218/Edg-5 to the g (i), g (q), and G (12) families of heterotrimeric G proteins. J Biol Chem 274:27351-27358, 1999
131. 131. GOETZL EJ, AN S: Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J 12:1589-1598, 1998
132. 132. WU J, SPIEGEL S, STURGILL TW: Sphingosine 1-phosphate rapidly activates the mitogen-activated protein kinase pathway by a G protein-dependent mechanism. J Biol Chem 270:11484-11488, 1995
133. 2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibition. J Biol Chem 273:27104-27110, 1998
134. 134. MEACCI E, VASTA V, MOORMAN JP, BOBAK DA, BRUNI P, MOSS J, VAUGHAN M: Effect of Rho and ADP-ribosylation factor GTPases on phospholipase D activity in intact human adenocarcinoma A549 cells. J Biol Chem 274:18605-18612, 1999
135. + current in guinea-pig atrial myocytes by sphingosine-1-phosphate. J Physiol (Lond) 489:701-707, 1995
136. 2+ signalling by G-protein-coupled receptors. EMBO J 17:2830-2837, 1998
137. 137. LEE MJ, VAN BROOKLYN JR, THANGADA S, LIU CH, HAND AR, MENZELEEV R, SPIEGEL S, HLA T: Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 269:1552-1555, 1998
138. 138. ANCILLIN N, HLA T: Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J Biol Chem 274:18997-19902, 1999
139. 139. GHOSH TK, BIAN J, GILL DL: Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium. J Biol Chem 269:22628-22635, 1994
140. 140. BUEHRER BM, BARDES ES, BELL RM: Protein kinase C-dependent regulation of human erythroleukemia (HEL) cell sphingosine kinase activity. Biochim Biophys Acta 1303:233-242, 1996
141. 141. RANI CS, WANG F, FUIOR E, BERGER A, WU J, STURGILL TW, LEROITH D, VARTICOVSKI L, SPIEGEL S: Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors: Involvement of sphingosine 1-phosphate in PDGF but not EGF signaling. J Biol Chem 272:10777-10783, 1997
142. 142. MELENDEZ A, FLOTO RA, GILLOOLY DJ, HARNETT MM, ALLEN JM: FcgammaRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. J Biol Chem 273:9393-9403, 1998
143. 143. EDSALL LC, VAN BROOKLYN JR, CUVILLIER O, KLEUSER B, SPIEGEL SN: N,N-dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: Modulation of cellular levels of sphingosine 1-kinase and ceramide. Biochemistry 37:12892-12898, 1998
144. 144. GALARDI S, KISHIKAWA K, KAMIBAYASHI C, MUMBY MC, HANNUM YA: Purification and characterization of ceramide-activated protein phosphatases. Biochemistry 37:11232-11238, 1998
145. 145. NICKELS JT, BROACH JR: A ceramide-activated protein phosphatase mediates ceramide-induced G1 arrest of Saccharomyces cerevisiae. Genes Dev 10:382-394, 1996
146. 146. CHALFANT CE, KISHIKAWA K, MUMBY MC, KAMIBAYASHI C, BIELAWSKA A, HANNUN YA: Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A: Activation is stereo-specific and regulated by phopshatidic acid. J Biol Chem 274: 20313-20317, 1999
147. 147. DBAIBO GS, PUSHKAREVA MY, JAYADEV S, SCHWARZ JK, HOROWITZ JM, OBEID LM, HANNUN YA: Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci USA 92:1347-1351, 1995
148. 148. ZHANG Y, YAO B, DELIKAT S, BAYOUMY S, LIN XH, BASU S, MCGINLEY M, CHAN-HUI PY, LICHENSTEIN H, KOLESNICK R: Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 89:63-72, 1997
149. 149. MATHIAS S, YOUNES A, KAN CC, ORLOW I, JOSEPH C, KOLESNICK RN: Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science 259:519-522, 1993
150. 150. MULLER G, AYOUB M, STORZ P, RENNECKE J, FABBRO D, PFIZENMAIER K: PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J 14:1961-1969, 1995
151. 151. HEINRICH M, WICKEL M, SCHNEIDER-BRACHERT W, SANDBERG C, GAHR J, SCHWANDNER R, WEBER T, SAFTIG P, PETERS C, BRUNNER J, KRONKE M, SCHUTZE S: Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J 18:5252-5263, 1999
152. 152. OBEID LM, LINARDIC CM, KAROLAK LA, HANNUN YA: Programmed cell death induced by ceramide. Science 259:1769-1771, 1993
153. 153. YOSHIMURA S, BANNO Y, NAKASHIMA S, HAYASHI K, YAMAKAWA H, SAWADA M, SAKAI N, NOZAWA Y: Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death. J Neurochem 73:675-683, 1999
154. 154. SANTANA P, PENA LA, HAIMOVITZ-FRIEDMAN A, MARTIN S, GREEN D, MCLOUGHLIN M, CORDON-CARDO C, SCHUCHMAN EH, FUKS Z, KOLESNICK R: Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 86:189-199, 1996
155. 155. AMARANTE-MENDES GP, NAEKYUNG KIM C, LIU L, HUANG Y, PERKINS CL, GREEN DR, BHALLA K: Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3. Blood 91:1700-1705, 1998
156. 156. TEPPER AD, DE VRIES E, VAN BLITTERSWIJK WJ, BORST J: Ordering of ceramide formation, caspase activation, and mitochondrial changes during CD95- and DNA damage-induced apoptosis. J Clin Invest 103:971-978, 1999
157. 157. DESNICK RJ, IOANNOU YA, ENG CM: Alpha-galactosidase A deficiency: Fabry disease, in The Metabolic and Molecular Bases of Inherited Disease (7th ed), New York, McGraw-Hill, pp 2741-2784, 1995
158. 158. BEUTLER E: Gaucher disease as a paradigm of current issues regarding single gene mutations of humans. Proc Natl Acad Sci USA 90:5384-5390, 1993
159. 159. SCHIFFMANN R, MURRAY GJ, TRECO D, DANIEL P, SELLOS-MOURA M, QUIRK JM, ZTRZOW GC, BOROWSKI M, LOVEDAY K, ANDERSON T, GILLESPIE F, OLIVER KL, JEFFRIES NO, DOO E, LIANG TJ, KREPS C, GUNTER K, FREI K, CRUTCHFTELD K, SELDEN RF, BRADY RO: Infusion of alpha-galactosidase A reduces tissue globotriaosyceramide storage in patients with Fabry disease. Proc Natl Acad Sci USA 97:365-370, 2000
160. 160. RADIN NS: Treatment of Gaucher disease with an enzyme inhibitor. Glycoconj J 13:153-157, 1996
161. 161. LIU Y, WADA R, KAWAI H, SANGO K, DENG C, TAI T, MCDONALD MP, ARAUJO K, CRAWLEY JN, BIERFREUND U, SANDHOFF K, SUZUKI K, PROIA RL: A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder. J Clin Invest 103:497-505, 1999
162. 162. PLATT FM, NEISES GR, REINKENSMEIER G, TOWNSEND MJ, PERRY VH, PROIA RL, WINCHESTER B, DWEK RA, BUTTERS TD: Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science 276:428-431, 1997
163. 163. JEYAKUMAR M, BUTTERS TD, CORTINA-BORJA M, HUNNAM V, PROIA RL, PERRY VH, DWEK RA, PLATT FM: Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin. Proc Natl Acad Sci USA 96:6388-6393, 1999
164. 164. ABE A, AREND LJ, LEE L, LINGWOOD C, BRADY RO, SHAYMAN JA: Glycosphingolipid depletion in Fabry disease lymphoblasts with potent inhibitors of glucosylceramide synthase. Kidney Int 57:446-454, 2000
165. 165. KARMALI MA, PETRIC M, LIM C, FLEMING PC, ARBUS GS, LIOR H: The association between isopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151:775-782, 1985
166. 166. NYHOLM PG, MAGNUSSON G, ZHENG Z, NOREL R, BINNINGTONBOYD B, LINGWOOD CA: Two distinct binding sites for globotriaosyl ceramide on verotoxins: Identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins. Chem Biol 3:263-275, 1996
167. 167. VAN DE KAR NC, MONNENS LA, KARMALI MA, VAN HINSBERGH VW: Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: Implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80:2755-2764, 1992
168. 168. WIELS J, HOLMES EH, COCHRAN N, TURSZ T, HAKOMORI S: Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid lines. J Biol Chem 259:14783-14787, 1984
169. 169. DICKIE P, FELSER J, ECKHAUS M, BRYANT J, SILVER J, MARINOS N, NOTKINS AL: HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185:109-119, 1991
170. i in rat aortic smooth muscle. Lipids 34:689-695, 1999
171. 171. IGARASHI J, THATTE HS, PRABHAKAR P, GOLAN DE, MICHEL T: Calcium-independent activation of endothelial nitric oxide synthase by ceramide. Proc Natl Acad Sci USA 96:12583-12588, 1999
172. 172. ZAGER RA, CONRAD DS, BURKHART K: Ceramide accumulation during oxidant renal tubular injury: Mechanisms and potential consequences. J Am Soc Nephrol 9:1670-1680, 1998
173. 173. UEDA N, KAUSHAL GP, HONG X, SHAH SV: Role of enhanced ceramide generation in DNA damage and cell death in chemical hypoxic injury to LLC-PK1 cells. Kidney Int 2:399-406, 1998